Excelerate Health Ventures
VC Fund
Durham, United States
Excelerate Health Ventures is a VC fund in Durham focused on Health Care and Medical. A healthcare-focused VC fund with an emphasis on early-stage healthcare SaaS and tech-enabled healthcare services with a B2B model. Our fund has a unique approach that leverages our investors - decision makers from pharma, providers, payers, and other strategic partners - to accelerate the adoption and revenues of our portfolio companies’ productsand services. To learn more, please visit: https://www.exceleratehealth.com/
- Total investments:
- 31
- Last investment:
- Lead investor:
- 52%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Excelerate Health Ventures invests in
Stages Excelerate Health Ventures invests in
Countries Excelerate Health Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
Investment Focus
Industry
- Health Care 16 (52%)
- Medical 6 (19%)
- Hospital 4 (13%)
- SaaS 3 (10%)
- Software 3 (10%)
Stage
- Series A 7 (23%)
- Funding Round 7 (23%)
- Seed 6 (19%)
- Series B 3 (10%)
- Venture - Series Unknown 3 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Andrew Schwab
Managing Partner
|
Managing Partner | Total investments: 4 | Find email | |
|
Bobby Bahram
Managing Partner
|
Managing Partner | Total investments: 7 | Find email | |
|
Bruce Boehm
Special Limited Partner
|
Special Limited Partner | Total investments: 4 | Find email | |
|
Cam Patterson
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
|
Gary Abrahams
Venture Partner
|
Venture Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
BEKHealth offers R&D platform solutions that will increase the efficiency and performance of clinical research operations. | $4M / Feb 13, 2025 | |
|
|
Korio is an IRT platform that focuses on industry compliance.Korio integrated the most recent IRT design intelligence into our solution to address the long-standing issues of operational inefficiencies, burdensome manual processes, and poor user experiences. | $5.5M / Series A / Sep 10, 2024 | |
|
|
S2N Health is a provider of cutting-edge strategy consulting services and SaaS solutions specifically designed for medical technology companies. Their aim is to optimize the impact and success of these companies' innovations. Since 2011, S2N Health has collaborated with over 160 companies, ranging from startups to large global organizations,providing valuable insights and analytics for crucial product, commercial, and business decisions. S2N Health offers comprehensive support throughout various stages, including development, market entry, sales acceleration, and strategic partnering. In 2022, they introduced RepSignal, an AI-driven SaaS solution that equips medtech commercial teams with on-demand customer insights and intelligence, enabling them to effectively target and engage clinical customers. | $4.3M / Seed / May 23, 2024 | |
|
|
Korio is an IRT platform that focuses on industry compliance.Korio integrated the most recent IRT design intelligence into our solution to address the long-standing issues of operational inefficiencies, burdensome manual processes, and poor user experiences. | $6.8M / Venture - Series Unknown / Oct 10, 2023 | |
|
|
Atalan develops a clinician wellness risk management software to help predict and address clinician burnout and turnover, using machine learning and labor economics. Atalan helps healthcare organizations to make more effective risk management decisions on clinician wellness. The company was founded in 2021 and is based in Boston, USA. | $2.5M / Seed / Oct 05, 2023 | |
|
|
Censinet fundamentally redefines the way vendor risk is managed in healthcare. Unlike other solutions, Censinet not only streamlines and simplifies workflows, but also standardizes risk questions with breadth and accuracy of risk ratings. Only Censinet was developed exclusively by and for healthcare providers, which makes Censinet the first andonly Collaborative Cloud Platform for Vendor Risk Management. | $9M / Venture - Series Unknown / Jan 11, 2023 | |
|
|
Doctivity Health offers cloud-based SaaS that focuses on actionable data and information to improve operating performance. | Jun 09, 2022 | |
|
|
Doctivity Health offers cloud-based SaaS that focuses on actionable data and information to improve operating performance. | $5.8M / Seed / Jun 03, 2022 | |
|
|
Healthcare is extremely inefficient due to complex and disparate systems that don’t talk to each other. The explosion of data further compounds the problem. Huma.AI improves (if not solves) this inefficiency by serving as the connective tissue between system silos allowing “mere mortals” to automatically access data, gain insights and take actionusing everyday language. | $9.5M / Series A / Feb 03, 2022 | |
|
|
BEKHealth offers R&D platform solutions that will increase the efficiency and performance of clinical research operations. | $4M / Seed / Jun 21, 2021 | |
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Excelerate Health Ventures invest in?
Excelerate Health Ventures invests primarily in Health Care, Medical and Hospital startups, most often at Series A and Funding Round stage. Most of the 31 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Excelerate Health Ventures?
Public channels for Excelerate Health Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Excelerate Health Ventures?
The team at Excelerate Health Ventures includes Andrew Schwab (Managing Partner), Bobby Bahram (Managing Partner) and Bruce Boehm (Special Limited Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!